Diabetic Macular Edema (DME) Latest Advances

The Efficacy and Safety of Subretinal Balanced Salt Solution Injection in Diabetic Macular Edema with Hard Exudates.

Journal: Retina (Philadelphia, Pa.)

Published: December 05, 2025

Cataract surgery in patients with diabetes mellitus: preoperative, intraoperative, and postoperative considerations.

Journal: Current opinion in ophthalmology

Published: December 04, 2025

Macular Microaneurysms Are Associated With Chronic Kidney Disease and Deep Capillary Plexus Ischemia in Referable Diabetic Retinopathy.

Journal: Investigative ophthalmology & visual science

Published: December 01, 2025

Sitagliptin does not interfere with VEGF-A signaling in retinal endothelial cells in vitro.

Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association

Published: November 25, 2025

Real-World Clinical Outcomes After Sustained Delivery of the 0.19 mg Fluocinolone Acetonide Implant for Treatment of Diabetic Macular Edema.

Journal: Journal of vitreoretinal diseases

Published: November 12, 2025

Advances in minimally traumatic retinal laser therapy.

Journal: Expert review of medical devices

Published: November 06, 2025

Protective Role of Axial Length in Diabetic Retinopathy: A Case-Control Study.

Journal: Cureus

Published: November 05, 2025

One-year Real-world Outcomes and Durability With Faricimab in Patients With Diabetic Macular Edema.

Journal: Ophthalmic surgery, lasers & imaging retina

Published: November 04, 2025

Evaluating anxiety and depression levels in patients undergoing intravitreal injections and investigation of contributing factors.

Journal: European journal of ophthalmology

Published: November 03, 2025

Macular Thickness Fluctuation as a Biomarker: Impact on Visual Acuity Following Antivascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.

Journal: Journal of vitreoretinal diseases

Published: November 03, 2025

Patient Reported Experiences and Comfort Associated with Intravitreal Injection Technique: A Cross-Sectional Survey Approach.

Journal: Journal of vitreoretinal diseases

Published: November 03, 2025

Beyond Vision: Prospective Real-World Evaluation of Quality-of-Life and Caregiver Burden in Diabetic Macular Edema Treated with Fluocinolone Acetonide (Iluvien®).

Journal: Ophthalmology and therapy

Published: October 28, 2025

Filters

The Efficacy and Safety of Subretinal Balanced Salt Solution Injection in Diabetic Macular Edema with Hard Exudates.

The Efficacy and Safety of Subretinal Balanced Salt Solution Injection in Diabetic Macular Edema with Hard Exudates.

Cataract surgery in patients with diabetes mellitus: preoperative, intraoperative, and postoperative considerations.

Cataract surgery in patients with diabetes mellitus: preoperative, intraoperative, and postoperative considerations.

Macular Microaneurysms Are Associated With Chronic Kidney Disease and Deep Capillary Plexus Ischemia in Referable Diabetic Retinopathy.

Macular Microaneurysms Are Associated With Chronic Kidney Disease and Deep Capillary Plexus Ischemia in Referable Diabetic Retinopathy.

Sitagliptin does not interfere with VEGF-A signaling in retinal endothelial cells in vitro.

Sitagliptin does not interfere with VEGF-A signaling in retinal endothelial cells in vitro.

Real-World Clinical Outcomes After Sustained Delivery of the 0.19 mg Fluocinolone Acetonide Implant for Treatment of Diabetic Macular Edema.

Real-World Clinical Outcomes After Sustained Delivery of the 0.19 mg Fluocinolone Acetonide Implant for Treatment of Diabetic Macular Edema.

Advances in minimally traumatic retinal laser therapy.

Advances in minimally traumatic retinal laser therapy.

Protective Role of Axial Length in Diabetic Retinopathy: A Case-Control Study.

Protective Role of Axial Length in Diabetic Retinopathy: A Case-Control Study.

One-year Real-world Outcomes and Durability With Faricimab in Patients With Diabetic Macular Edema.

One-year Real-world Outcomes and Durability With Faricimab in Patients With Diabetic Macular Edema.

Evaluating anxiety and depression levels in patients undergoing intravitreal injections and investigation of contributing factors.

Evaluating anxiety and depression levels in patients undergoing intravitreal injections and investigation of contributing factors.

Macular Thickness Fluctuation as a Biomarker: Impact on Visual Acuity Following Antivascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.

Macular Thickness Fluctuation as a Biomarker: Impact on Visual Acuity Following Antivascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.

Patient Reported Experiences and Comfort Associated with Intravitreal Injection Technique: A Cross-Sectional Survey Approach.

Patient Reported Experiences and Comfort Associated with Intravitreal Injection Technique: A Cross-Sectional Survey Approach.

Beyond Vision: Prospective Real-World Evaluation of Quality-of-Life and Caregiver Burden in Diabetic Macular Edema Treated with Fluocinolone Acetonide (Iluvien®).

Beyond Vision: Prospective Real-World Evaluation of Quality-of-Life and Caregiver Burden in Diabetic Macular Edema Treated with Fluocinolone Acetonide (Iluvien®).